Cencora EBITDA 2010-2025 | COR
- Cencora EBITDA for the quarter ending March 31, 2025 was $1.300B, a 56.08% increase year-over-year.
- Cencora EBITDA for the twelve months ending March 31, 2025 was $3.648B, a 0.15% increase year-over-year.
- Cencora 2024 annual EBITDA was $3.294B, a 0.83% decline from 2023.
- Cencora 2023 annual EBITDA was $3.322B, a 7.98% increase from 2022.
- Cencora 2022 annual EBITDA was $3.076B, a 6.05% increase from 2021.
Cencora Annual EBITDA (Millions of US $) |
|
---|---|
2024 | $3,294 |
2023 | $3,322 |
2022 | $3,076 |
2021 | $2,901 |
2020 | $-4,366 |
2019 | $1,609 |
2018 | $2,013 |
2017 | $1,493 |
2016 | $1,918 |
2015 | $678 |
2014 | $979 |
2013 | $1,069 |
2012 | $1,444 |
2011 | $1,296 |
2010 | $1,181 |
2009 | $978 |
Cencora Quarterly EBITDA (Millions of US $) |
|
---|---|
2025-03-31 | $1,300 |
2024-12-31 | $988 |
2024-09-30 | $406 |
2024-06-30 | $953 |
2024-03-31 | $833 |
2023-12-31 | $1,101 |
2023-09-30 | $761 |
2023-06-30 | $947 |
2023-03-31 | $805 |
2022-12-31 | $809 |
2022-09-30 | $629 |
2022-06-30 | $663 |
2022-03-31 | $960 |
2021-12-31 | $825 |
2021-09-30 | $768 |
2021-06-30 | $752 |
2021-03-31 | $729 |
2020-12-31 | $652 |
2020-09-30 | $-5,652 |
2020-06-30 | $504 |
2020-03-31 | $410 |
2019-12-31 | $373 |
2019-09-30 | $293 |
2019-06-30 | $519 |
2019-03-31 | $184 |
2018-12-31 | $613 |
2018-09-30 | $341 |
2018-06-30 | $535 |
2018-03-31 | $607 |
2017-12-31 | $531 |
2017-09-30 | $-23 |
2017-06-30 | $278 |
2017-03-31 | $731 |
2016-12-31 | $506 |
2016-09-30 | $328 |
2016-06-30 | $629 |
2016-03-31 | $1,050 |
2015-12-31 | $-89 |
2015-09-30 | $620 |
2015-06-30 | $403 |
2015-03-31 | $-308 |
2014-12-31 | $-37 |
2014-09-30 | $266 |
2014-06-30 | $160 |
2014-03-31 | $347 |
2013-12-31 | $205 |
2013-09-30 | $158 |
2013-06-30 | $178 |
2013-03-31 | $392 |
2012-12-31 | $341 |
2012-09-30 | $361 |
2012-06-30 | $361 |
2012-03-31 | $409 |
2011-12-31 | $313 |
2011-09-30 | $245 |
2011-06-30 | $349 |
2011-03-31 | $396 |
2010-12-31 | $307 |
2010-09-30 | $250 |
2010-06-30 | $308 |
2010-03-31 | $336 |
2009-12-31 | $288 |
2009-09-30 | $250 |
2009-06-30 | $237 |
2009-03-31 | $271 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $56.726B | $293.959B |
CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $134.596B | 25.24 |
CVS Health (CVS) | United States | $77.976B | 9.69 |
Elevance Health (ELV) | United States | $62.251B | 8.37 |
DiDi Global (DIDIY) | China | $26.168B | 27.80 |
Labcorp Holdings (LH) | United States | $20.342B | 16.50 |
Natera (NTRA) | United States | $19.203B | 0.00 |
BioMerieux (BMXMF) | France | $16.276B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $13.895B | 0.00 |
CochLear (CHEOY) | Australia | $13.050B | 0.00 |
Solventum (SOLV) | United States | $12.516B | 13.25 |
ICON (ICLR) | Ireland | $11.276B | 10.48 |
Revvity (RVTY) | United States | $10.693B | 18.40 |
Viatris (VTRS) | United States | $10.446B | 3.59 |
Medpace Holdings (MEDP) | United States | $8.878B | 22.97 |
Sonic Healthcare (SKHHY) | Australia | $8.792B | 0.00 |
Avantor (AVTR) | United States | $8.409B | 12.22 |
HealthEquity (HQY) | United States | $8.395B | 36.77 |
Charles River Laboratories (CRL) | United States | $7.357B | 14.42 |
Caris Life Sciences,�Inc (CAI) | United States | $7.197B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.928B | 29.02 |
BrightSpring Health Services (BTSG) | United States | $3.465B | 31.79 |
Sotera Health (SHC) | United States | $3.125B | 17.76 |
Surgery Partners (SGRY) | United States | $2.866B | 37.27 |
Concentras Parent (CON) | United States | $2.557B | 14.78 |
Alignment Healthcare (ALHC) | United States | $2.473B | 0.00 |
Organon (OGN) | United States | $2.457B | 2.61 |
GeneDx Holdings (WGS) | United States | $2.235B | 86.09 |
Progyny (PGNY) | United States | $1.966B | 43.28 |
PACS (PACS) | United States | $1.771B | 0.00 |
Premier (PINC) | United States | $1.723B | 13.08 |
GoodRx Holdings (GDRX) | United States | $1.697B | 33.93 |
Ardent Health (ARDT) | United States | $1.566B | 6.68 |
Teladoc Health (TDOC) | United States | $1.461B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.232B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.086B | 8.26 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
Agilon Health (AGL) | United States | $0.886B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.711B | 6.66 |
CareDx (CDNA) | United States | $0.710B | 11.09 |
Nutex Health (NUTX) | United States | $0.618B | 9.35 |
Embecta (EMBC) | United States | $0.601B | 4.05 |
So-Young (SY) | China | $0.581B | 0.00 |
SBC Medicals (SBC) | United States | $0.541B | 0.00 |
InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
LifeMD (LFMD) | United States | $0.474B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
Omada Health (OMDA) | $0.466B | 0.00 | |
COMPASS Pathways (CMPS) | United Kingdom | $0.417B | 0.00 |
Enhabit (EHAB) | United States | $0.340B | 28.00 |
Oncology Institute (TOI) | United States | $0.304B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.295B | 0.00 |
Beauty Health (SKIN) | United States | $0.209B | 0.00 |
Pheton Holdings (PTHL) | China | $0.149B | 0.00 |
DocGo (DCGO) | United States | $0.145B | 23.67 |
Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
KindlyMD (NAKA) | United States | $0.066B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
Biodesix (BDSX) | United States | $0.051B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.043B | 0.00 |
ModivCare (MODV) | United States | $0.042B | 0.00 |
OSR Holdings (OSRH) | United States | $0.021B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.014B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
XWELL (XWEL) | United States | $0.007B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |